Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US FDA Could Be Mostly Spared From Trump's Regulation-Slashing Order

Feb 13 2017

• By Derrick Gingery

Related Content

Trump's Two-For-One Reg Order Needs Agency Interpretation, Medtech Reg Experts Say

Jan 31 2017

Public Citizen Challenges Trump's Regulation Executive Order

Feb 13 2017

Trump Order Reducing Regulation Might Imperil FDA Good Guidance Practices

Jan 31 2017

FDA's Document Dump: Guidance Release Skyrockets Ahead Of Trump's Arrival

Jan 22 2017

Additional Topics

United States Regulation FDA Elections Medical Device In Vitro Diagnostics

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window